San Francisco, 18 December 2018: The Report Regenerative Medicine Market Analysis By Product (Therapeutics {Primary Cell-based,
Stem Cell-based, Immunotherapies, & Gene Therapies}, Tools, Banks, &
Services), By Therapeutic Category, And Segment Forecasts, 2018 - 2025
According to a report by Grand
View Research, Inc.; the global regenerative medicine market is projected to
value USD 5.59 billion by 2025. High prevalence of orthopedic,
neurodegenerative, and other aging-related disorders is anticipated to propel
the market. Rise in geriatric population can further fuel market expansion over
the forecast period (2014 to 2025).
Continual technological
advancements in tissue engineering, gene therapy, and nanotechnology can
stimulate expansion of the market for regenerative medicine. Increasing R&D
investments by private and government organizations can also impel growth. Rapid
developments in biotechnology provide in-depth knowledge regarding metabolism
mechanism, cell division, and cell differentiation. Development of new streams
of biotechnology like nanotechnology and gene therapy can augment use of
cell-based technology in therapeutic procedures. This, in turn, can stimulate
market expansion in the forthcoming years.
The worldwide regenerative
medicine market is segregated on the basis of product, therapeutic category,
and region. Based on product, the market is categorized into therapeutics and
devices, stem cell and progenitor cell-based therapeutics, banks, tools, and
services. In 2016, therapeutics held the largest market share owing to high
implementation. Introduction of various gene and cell-based therapies is expected
to contribute to the growth.
Access Research Report of Regenerative Medicine Market@ www.grandviewresearch.com/industry-analysis/regenerative-medicine-market
In addition, emergence of
regulatory policies to promote research activities related to cell therapy can positively
influence market expansion. Such supportive policies can encourage researchers
to further explore induced Pluripotent Stem Cells (iPSC). Moreover, development
of gene therapy techniques to restore and rectify effects of gene mutations in
cells is underway. Mutations inducing degenerative characteristics along with to
the conditions caused by Single Nucleotide Polymorphism (SNP) are targeted by
these gene therapies.
On the contrary, stringent
regulations regarding the use of Human Embryonic Stem Cells (HESC) may restrict
growth of the market for regenerative medicine. However, regulatory changes
introduced by countries like United Kingdom, United States, China, and Japan
attributed to identification of clinical applications are expected to augment
market expansion in the forthcoming years.
Based on therapeutic category,
the market can be classified into oncology, musculoskeletal, cardiovascular,
ophthalmology, dermatology, immunology and inflammation, and others. Dermatology
is projected to hold the largest market share during the forecast period.
Availability of easy drafting methods to treat dermatology diseases and wounds
can propel growth of segment. Skin is an organ that offers great cell
replication characteristics. Different types of stem cells are found in different
layers of skin. Availability of wide range of products like patches and grafts to
treat minor injuries and chronic burns and wounds respectively, can stimulate segment
growth during the forecast period.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Oncology is estimated to witness
the most significant growth over the forecast period. Rising investment in
research activities and availability of pipeline products can propel this
expansion. High prevalence of cancer and increasing expenses for treatment can positively
influence growth. However, challenges associated with clinical experiments are
expected to hinder the expansion in near future.
Regional segmentation includes
North America, Asia Pacific, Europe, Latin America, and Middle East and Africa.
North America is anticipated to hold the largest market share attributed to presence
of leading market players. In addition, continual technological advancements
and investments in oncology and stem cells research can further augment
regional growth.
Asia Pacific is projected to
witness the fastest CAGR over the forecast period attributed to rising healthcare
investments by growing economies. Technological advancements in stem cell
research can further propel regional market for regenerative medicine. In
addition, availability of flexible regulations regarding adoption of cell-based
regenerative therapies can boost market expansion. Moreover, growing
investments by private and government companies to boost development of novel
technologies can stimulate market growth over the forecast period.
Some of the leading companies operating in the regenerative
medicine market are Integra LifeSciences Corporation, Corline Biomedical AB,
Bayer BV, F. Hoffmann-La Roche Ltd, and Vericel Corporation. Most companies are
likely to invest in development of regenerative therapies to capture untapped
opportunities in the field. They focus on developing novel therapies that can
meet clinical requirements.
Access
Press Release of Regenerative Medicine Market@
www.grandviewresearch.com/press-release/global-regenerative-medicine-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range of
industries, from technology to chemicals, materials and healthcare.
No comments:
Post a Comment